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Previewsantibiotic-induced iNOS induction is
already sufficient to foster Enterobacter-
iaceae overgrowth.
In summary, recent work has pro-
vided unprecedented insights into the
complex mechanisms of infections by
antibiotic-dependent pathogens (Ng
et al., 2013; Spees et al., 2013). On the
one hand, antibiotics insult the delicate
crosstalk between the microbiota and
the mucosal immune system, thereby
leading to alteration of immune homeo-
stasis, which ultimately increases sus-
ceptibility to pathogens. On the other
hand, antibiotic-dependent disruption of
microbial ecology generates free nutrient
niches, which can be exploited by patho-
gens for infiltrating this complex and sta-
ble ecosystem to initiate disease. Giventhe increased thread of antibiotic-depen-
dent pathogens in hospital settings, the
work of Ng et al. (2013) provides an impor-
tant basis for the future development
of therapeutic intervention against these
infections.REFERENCES
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Cholera toxin (CT) is the factor responsible for watery diarrhea associated with Vibrio cholerae infection. In
this issue, Guichard et al. (2013) report that CT compromises intestinal epithelium barrier function via cyclic
AMP (cAMP)-induced disruption of Rab11- and exocyst-dependent delivery of endocytic recycling cargo to
cell-cell junctions.Infections by Vibrio cholerae remain a
global public health burden. Cholera toxin
(CT) is the toxic factor responsible for the
induction of a unique, profuse, watery
diarrhea of typically 10 to 20 l a day in
adult patients infected by toxigenic
strains of Vibrio cholerae. CT is closely
homologous to the heat-labile toxin pro-
duced by toxigenic strains of Escherichia
coli, the causative agent of traveler’s
diarrhea. As with other enteropathogens
triggering watery diarrhea, the mecha-
nism by which water flows across and
out of the epithelium is not fully under-
stood. Now, Guichard et al. (2013) reveal
that dysfunction of Rab11 and exocyst
machinery, which is triggered by CT via
forced induction of cyclic AMP (cAMP)
signaling, compromises epithelium bar-rier integrity and contributes to efflux
of water and solutes associated with
V. cholera infection.
CT belongs to the AB5 family of toxins. It
is composed of an enzyme (A subunit,
CtxA) associatedwith a pentameric crown
of B polypeptides for binding to GM1 gan-
gliosides at the surface of host cells. CT
enters into cellular vesicles and un-
dergoes a retrograde traffic to the endo-
plasmic reticulum, where the A subunit
translocates into the cytosol. CtxA is a
mono-ADP-ribosyltransferase that works
in combination with the ADP-ribosylation
factor 6 (ARF6) cellular cofactor. CtxA cat-
alyzes the transfer of an ADP-ribose from
nicotinamide adenine dinucleotide (NAD)
onto a key arginine residue in the a-stimu-
lating subunits of heterotrimeric G pro-teins (Gsa). This leads to the activation of
cellular adenylate cyclases at the plasma
membrane provoking a pathological rise
of cAMP. cAMP is a broad signalingmole-
cule that activates different cellular fac-
tors, such as the cAMP-dependent pro-
tein kinase A (PKA), thereby inducing the
phosphorylation of several ion channels.
Notably, this activates the conductance
of the cystic fibrosis transmembrane
conductance regulator (CFTR), a chloride
ion channel (Gabriel et al., 1994). CFTR
drives the efflux of Cl ions and the result-
ing compensatory, andpartly paracellular,
secretion of Na+ (Gabriel et al., 1994). The
net secretion of sodium chloride (NaCl)
generates an osmotic gradient that is
compensated by water efflux. Both
basolaterally located K+ channels and anptember 11, 2013 ª2013 Elsevier Inc. 227
Figure 1. Central Role of Rab11-Driven Vesicular Trafficking in
Pathogen Interactions with Intestinal Epithelium
Adherens junction (AJ) molecules (green), such as E-cadherin and beta-cate-
nin, maintain epithelia cell-cell cohesion. In vertebrates, tight junction (TJ)
molecules (yellow), such as claudin-2 and ZO1 (shown above AJs), limit the
paracellular permeability. TJmolecules are also essential for the establishment
of epithelial cell polarity, owing to their properties to restrict the apicobasal
diffusion of molecules such as the Notch receptor ligand Delta. Rab11 drives
the vesicular trafficking of cargo from endocytic recycling compartments (EC)
and trans-Golgi network (TGN) to specific areas at the plasma membrane. (1)
Guichard et al. (2013) show the impact of CT-driven forced induction of cAMP
signaling on Rab11-driven Sec15-exocyst-dependent trafficking of E-cad-
herin at AJs. (2) Shigella triggers a tubulation of Rab11-positive compartment,
also impairing E-cadherin targeting to plasma membrane. (3) The noxious
effects of small pore-forming toxins are limited by Rab11-driven expulsion of
microvilli lined with toxin molecules. (4) Rab11 is critical for the assembly, traf-
ficking, and budding of negative-strand RNA viruses.
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cotransporter cooperate to
establish the osmotic
gradient.
The study of infectious dis-
eases in genetically tractable
model organisms, such as
the fruit fly Drosophila mela-
nogaster, is a valuable strat-
egy to pinpoint major actors
in host pathogen interac-
tions. Flies infected with the
bacterium V. cholerae
display weight loss and
increased mortality (Blow
et al., 2005). By direct cyto-
solic expression of the
catalytic subunit of cholera
toxin in Drosophila cells
in vivo, combined with ge-
netic approaches, Guichard
et al. (2013) reveal that acti-
vation of both Gsa and the
Drosophila adenylate cyclase
rutabaga triggers a pheno-
type of the wings reminiscent
of the Notch mutant pheno-
type. Epistasis experiments
demonstrate that CtxA acts
downstream of the Notch
ligand Delta (Dl) and up-
stream of the Notch receptor.
Stimulation of Notch requires
trafficking of Dl fromthe apical face of the epithelia to
the basolateral side via the endocytic
recycling compartments (EC) (Figure 1).
Transfer of cargo from EC to the basolat-
eral side is under the control of the
small guanosine triphosphatase (GTPase)
Rab11 and its effector Sec15, a compo-
nent of the exocyst complex (Guichard
et al., 2010; Heider and Munson, 2012).
Guichard et al. (2013) reveal that CtxA
induces a decrease of cellular levels
of Rab11 and Sec15-GFP at the apical
side of epithelial cells. This affects the
Rab11-driven transfer of endocytic recy-
cling cargo, thus restricting levels of
adherens junction (AJ) molecules to the
basolateral face of the epithelium. More-
over, the expression of CtxA in mature
enterocytes of the midgut has a profound
impact on the level and distribution of
cadherin and beta-catenin at AJs, with
major consequences on intercellular
membrane apposition, as evidenced by
transmission electron microscopy. By
feeding the flies with a colored food dye228 Cell Host & Microbe 14, September 11, 2and assessing dye diffusion in tissues,
the authors clearly demonstrate that
expression of CtxA or a dominant-
negative form of Rab11 induces loss of
epithelial barrier integrity. Overexpression
of the wild-type Rab11 rescues CtxA-
induced disruption of AJ integrity and
epithelium barrier function. Moreover,
the overexpression of Rab11 has a pro-
tective effect in a model of CtxA-driven
V. cholera infection in flies.
The authors further examine the cyto-
toxic effects of CT on human intestinal
epithelial cell monolayers. Intoxication
results in a dramatic reduction of E-
cadherin staining associated with its
redistribution along the entire apical-
basal axis, while the staining of the tight
junction (TJ) molecules ZO1 and Clau-
din-2 remains restricted to apical regions.
Nevertheless, the TJ adopts a convoluted
organization with a loss of apposition
with AJs. A few gaps in ZO1 staining
at TJ are also evidenced. The use of
pharmacological inhibitors and analogs013 ª2013 Elsevier Inc.implicates the cAMP effectors
Epac and PKA in these cyto-
toxic effects. Overexpression
of Rab11 restores cadherin
signal at AJs and reduces
the extent of intercellular
gaps. Analysis of CT effects
on a model of ligated murine
ileal loop also reveals cell-
cell disjunctions associated
with an accumulation of albu-
min in the lumen.
This study thus ascribes to
cholera toxin a new cytotoxic
feature, namely the disruption
of the intestinal epithelium
barrier by targeting Rab11, a
critical component of endo-
cytic recycling compart-
ments. This represents a ma-
jor step forward in our
understanding of the molecu-
lar basis for themassive water
efflux induced by CT. An
exciting challenge for future
studies will be to establish
the molecular link between
the cAMP-driven Epac/PKA
signaling axis and Rab11.
Moreover, it will be important
to decipher why the amplitude
and duration of cAMP
signaling induced by several
toxins trigger a rupture ofepithelial and endothelial barriers,
whereas physiological stimuli rather
tighten these barriers.
Interestingly, a series of recent find-
ings points to the importance of Rab11
signaling in host pathogen interactions
(Figure 1). The adenylate cyclase toxin
(edema toxin) from Bacillus anthracis
disrupts endothelial cell adherens junc-
tion cohesion by corrupting the Rab11
and exocyst machinery (Guichard et al.,
2010). Shigella flexneri compromises
the organization and trafficking of cargo
through Rab11-dependent Golgi and
endocytic recycling endosomes by cor-
rupting cholesterol distribution (Mounier
et al., 2012). As reported for CT, this
phenomenon likely also contributes to
disrupting the trafficking of epithelial
cell AJ molecules. Rab11 is also instru-
mental for the assembly, trafficking,
and budding of some enveloped viruses
(Bruce et al., 2012). Chlamydia tracho-
matis usurps Rab11 signaling in order
to fragment the Golgi apparatus and
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Lipinski et al., 2009). Conversely,
Rab11 actively limits the noxious perme-
abilization effect of small pore-forming
toxins (Los et al., 2011). Cells achieve
this notably by expelling microvilli by a
Rab11-dependent mechanism, likely
requiring vesicle fusion. Rab11 also con-
trols the trafficking of the Toll-like recep-
tor 4 (TLR4) from endocytic recycling
compartments to phagosomes contain-
ing Escherichia coli. This allows a local
stimulation of TLR4 together with inter-
feron regulatory factor 3 (IRF3) for
robust production of interferon-g (Huse-
bye et al., 2010). Collectively, these
studies point to a critical function of
Rab11 signaling in host pathogen
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In this issue ofCell Host &Microbe, Varble et al. (2013) engineer a library of RNA viruses to express small inter-
fering RNAs and couple this with the power of virus evolution and selection to screen for host genes that when
silenced resulted in greater viral infection in vivo.Over the last five years, a variety of
screening methods have been used to
identify host factors that restrict viral
infection. Some investigators have used
genome-wide screening approaches,
whereas others have targeted specific
antiviral pathways, including the type I
interferon (IFN) response. Experimentally,
these screens have relied on short hairpin
RNA-based gene silencing or ectopic
gene expression largely in transformed
cell culture models of virus infection. In
gene silencing approaches, virus infec-
tivity is enhanced when expression of
restriction factors is diminished. In the
context of treating cells with exogenous
IFN, gene silencing can define the relativecontribution of individual interferon-
stimulated genes (ISGs) to the host anti-
viral responses. In ectopic expression
screens, particularly of genes in the IFN
signaling and effector pathway, host
factors that are sufficient to protect cells
from virus infection have been revealed.
Each screening method has strengths
and limitations. In genome-wide siRNA
screening approaches, an underlying
assumption is that a restriction factor will
be expressed basally at levels that are
sufficient to control an incoming virus.
The identification of the antiviral activity
of IFITM gene family members is a suc-
cessful example of this strategy (Brass
et al., 2009). Other genome-wide siRNAscreens have been performed in the
context of IFN treatment and uncovered
numerous putative host restriction fac-
tors, many of which regulate cellular
antiviral responses even though they are
not induced by IFN (Fusco et al., 2013;
Zhao et al., 2012). Two screens that
specifically targeted the IFN pathway by
silencing a comprehensive panel of ISGs
identified novel host factors that had
direct effector functions or regulated IFN
response pathways (Li et al., 2013; Metz
et al., 2012). In addition to gene silencing
strategies, ectopic expression screens
also have identified ISGs that inhibit virus
infection. When hundreds of ISGs were
tested for their ability to suppress virusptember 11, 2013 ª2013 Elsevier Inc. 229
